CUE SCHEDULE 13G/A: SEC filing
A joint filing agreement was
Filed with the SEC on · accession 0001213900-26-107721
CUE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 8, 2026. A joint filing agreement was filed by Mark E. The stock moved -0.8% by the first close after the filing.
Summary of the filing
A joint filing agreement was filed by Mark E. Strome and affiliated Strome entities regarding a Schedule 13G/A for Cue Biopharma, Inc. The agreement allows the reporting persons to file amendments jointly without additional filing agreements.
Key details
How CUE stock reacted
Close before
$22.51
Oct 7, 2026
First close after
-0.80%
$22.33
5 trading days
-17.37%
$18.60
Since filing
-13.73%
$19.42
✦ Ask GOAX AI about this filing — what it means for CUE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CUE?
Click hereFrequently asked questions
What did CUE file with the SEC on Oct 8, 2026?
CUE filed a SCHEDULE 13G/A (SEC filing). A joint filing agreement was filed by Mark E. Strome and affiliated Strome entities regarding a Schedule 13G/A for Cue Biopharma, Inc. The agreement allows the reporting persons to file amendments jointly without additional filing agreements.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CUE stock react to this filing?
CUE closed at $22.51 before the filing and $22.33 on Oct 8, 2026 (-0.80%). Five trading days later: $18.60 (-17.37%).
Other CUE SEC filings
Get alerts when CUE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days